Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.
October 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 |
November 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
December 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
Press releases published on October 15, 2025
October 15, 2025
Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies
Indeterminate
GlobeNewswire
October 15, 2025
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
Indeterminate
GlobeNewswire
October 15, 2025
Mutuum Finance Nears Q4 2025 Launch Following Recent Announcement
Indeterminate
GlobeNewswire
October 15, 2025
Rezolute to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 15, 2025
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
Indeterminate
GlobeNewswire
October 15, 2025
illumin Welcomes Adtech Leader Brian Garrigan as Chief Revenue Officer to Champion Customer Growth and Innovation
Indeterminate
GlobeNewswire
October 15, 2025
Core AI’s Expands Into AI Driven Media Production
Indeterminate
GlobeNewswire
October 15, 2025
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
Indeterminate
GlobeNewswire
October 15, 2025
Minovia Therapeutics קיבלה את אישור תרופת היתום של ה-FDA עבור MNV-201 בתסמונת מיאלודיספלסטית
Indeterminate
GlobeNewswire
October 15, 2025
3 E Network Technology Group Limited Announces Amendment to Its $7.4 Million Convertible Notes Offering
Indeterminate
GlobeNewswire
October 15, 2025
Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
Indeterminate
GlobeNewswire
October 15, 2025
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
Indeterminate
GlobeNewswire
October 15, 2025
Using your voice will completely reshape how we work with AI new study finds
Indeterminate
GlobeNewswire